Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Regression of atherosclerosis in apolipoprotein E-deficient mice by lentivirus-mediated gene silencing of lipoprotein-associated phospholipase A2.

Zhang H, Zhang J, Shen D, Zhang L, He F, Dang Y, Li L.

Biochem Biophys Res Commun. 2012 Oct 26;427(3):557-62. doi: 10.1016/j.bbrc.2012.09.096. Epub 2012 Sep 26.

PMID:
23022183
2.

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.

Zhang H, Zhang JY, Sun TW, Shen DL, He F, Dang YH, Li L.

Clin Invest Med. 2013 Feb 1;36(1):E32-41.

PMID:
23374598
3.

Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.

Zhang H, Zhang J, Shen D, Zhang L, He F, Dang Y, Li L.

Int J Mol Med. 2013 Mar;31(3):651-9. doi: 10.3892/ijmm.2013.1248. Epub 2013 Jan 16.

PMID:
23338278
4.

Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40.

Wang B, Qian H, Yang H, Xu L, Xu W, Yan J.

Int J Cardiol. 2013 Feb 10;163(1):34-9. doi: 10.1016/j.ijcard.2011.05.053. Epub 2011 Jun 2.

PMID:
21640399
5.

Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice.

Wang X, Li L, Li M, Dang X, Wan L, Wang N, Bi X, Gu C, Qiu S, Niu X, Zhu X, Wang L.

Int J Mol Med. 2013 Nov;32(5):1215-21. doi: 10.3892/ijmm.2013.1494. Epub 2013 Sep 12.

PMID:
24043133
6.

[The impact of cyclophilin A small interfering RNA on the formation of atherosclerotic plaque in apolipoprotein E-deficient mice].

Yan J, Li Y, Wang C, Yuan W, Wang Z.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jul;42(7):593-7. Chinese.

PMID:
25327603
7.

Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.

Wang WY, Zhang J, Wu WY, Li J, Ma YL, Chen WH, Yan H, Wang K, Xu WW, Shen JH, Wang YP.

PLoS One. 2011;6(8):e23425. doi: 10.1371/journal.pone.0023425. Epub 2011 Aug 31.

8.

Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.

Qi LH, Wang Y, Gao F, Zhang C, Ding SF, Ni M, Feng JB, Zhang Y.

Hum Gene Ther. 2009 Jul;20(7):739-50. doi: 10.1089/hum.2008.203.

PMID:
19278303
9.

Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.

Liu XL, Zhang PF, Ding SF, Wang Y, Zhang M, Zhao YX, Ni M, Zhang Y.

PLoS One. 2012;7(3):e33497. doi: 10.1371/journal.pone.0033497. Epub 2012 Mar 12.

10.

RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice.

Zhou WP, Zhang H, Zhao YX, Liu GQ, Zhang JY.

PLoS One. 2015 Mar 20;10(3):e0121823. doi: 10.1371/journal.pone.0121823. eCollection 2015.

11.

The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice.

Hu MM, Zhang J, Wang WY, Wu WY, Ma YL, Chen WH, Wang YP.

Acta Pharmacol Sin. 2011 Oct;32(10):1253-8. doi: 10.1038/aps.2011.127. Epub 2011 Aug 15.

12.
13.

[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].

Sertić J, Skorić B, Lovrić J, Bozina T, Reiner Z.

Acta Med Croatica. 2010 Oct;64(4):237-45. Review. Croatian.

PMID:
21688606
14.

Utility of Lp-PLA2 in lipid-lowering therapy.

Racherla S, Arora R.

Am J Ther. 2012 Mar;19(2):115-20. doi: 10.1097/MJT.0b013e3181e70d32. Review.

PMID:
20634673
16.

Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.

Zheng F, Xing S, Gong Z, Mu W, Xing Q.

Mediators Inflamm. 2014;2014:507208. doi: 10.1155/2014/507208. Epub 2014 Jun 4.

17.

Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.

Epps KC, Wilensky RL.

J Intern Med. 2011 Jan;269(1):94-106. doi: 10.1111/j.1365-2796.2010.02297.x. Epub 2010 Nov 5. Review.

18.

Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice.

Yang JM, Wang Y, Qi LH, Wang Y, Gao F, Ding SF, Ni M, Liu CX, Zhang C, Zhang Y.

J Cell Mol Med. 2011 Mar;15(3):602-11. doi: 10.1111/j.1582-4934.2010.01028.x.

19.

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Rosenson RS, Stafforini DM.

J Lipid Res. 2012 Sep;53(9):1767-82. doi: 10.1194/jlr.R024190. Epub 2012 Jun 4. Review.

20.

[Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].

Luo RN, Tao LJ, Zhou J, Wang R, Lu MM, Fu X.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug;39(8):743-8. Chinese.

PMID:
22169423

Supplemental Content

Support Center